6 Meridian’s Amedisys AMED Stock Holding History

6 Meridian’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-807	Closed	-$237K	–	400
2020 Q4	$237K	Buy	+807	New	+$207K	0.02%	246

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

6 Meridian's AMED Position: Q1 2021 in Review

6 Meridian sold out of Amedisys (AMED) in Q1 2021, closing a stake of 807 shares — an estimated $237K sold.

6 Meridian first reported a position in AMED in Q4 2020 and held it in 1 quarter. The position peaked at $237K in Q4 2020. 388 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

6 Meridian reported no remaining Amedisys position as of Q1 2021 after selling out during the quarter.
6 Meridian sold 807 Amedisys shares in Q1 2021, an estimated $237K.
6 Meridian first reported a position in Amedisys in Q4 2020 and held it in 1 quarter.
6 Meridian's Amedisys position peaked at $237K in Q4 2020.
388 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on 6 Meridian's 13F filing for Q1 2021, filed 22 Apr 2021.